Atlas FDA

Eversense Continuous Glucose Monitoring System (CGMS-Entire System), Eversense Sensor , Eversense Insertion Tools, Evers

FDA premarket approval P160048/S003 · decided 2019-02-01

Approval details

PMA number
P160048
Supplement
S003
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Eversense Continuous Glucose Monitoring System (CGMS-Entire System), Eversense Sensor , Eversense Insertion Tools, Evers
Generic name
Continuous glucose monitor, implanted, adjunctive use
Applicant
Senseonics, Incorporated
Date received
2018-08-27
Decision date
2019-02-01
Days to decision
158 days
Decision code
APPR
Product code
QCD
Advisory committee
Clinical Chemistry
Expedited review
No
Location
Germantown, MD
Statement
Approval to add final packaging, storage, and distribution activities for the Eversense Continuous Glucose Monitoring System at Woodfield Distribution, LLC, Boca Raton, FL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Eversense 365 Continuous Glucose Monitoring (CGM) System (K241335)Senseonics, Incorporated2024-09-16
Eversense AP CGM System (DEN230052)Senseonics, Incorporated2024-04-29